Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Specificity of the activation of ( sup 3 H)hemicholinium-3 binding by phospholipase A2

Journal Article · · Journal of Pharmacology and Experimental Therapeutics; (USA)
OSTI ID:5564302
; ;  [1]
  1. Johns Hopkins Univ. School of Medicine, Baltimore, MD (USA)
Phospholipase A2 (PLA2) treatment has been shown previously to stimulate the sodium-dependent high-affinity choline uptake system as assessed by both the specific binding of (3H)hemicholinium-3 (( 3H)HCh-3) and the uptake of (3H)choline. In the present study, the specificity of PLA2-induced stimulation upon (3H)HCh-3 binding has been examined. PLA2, as well as phospholipase C (PLC), treatment of synaptic membranes produced a dose-dependent increase in the specific binding of (3H)HCh-3 whereas neither phospholipase B nor phospholipase D had any effect. PLC-induced stimulation of (3H)HCh-3 binding resulted from a significant decrease in the Kd without a change in the maximum binding of (3H)HCh-3 binding. PLC treatment of synaptosomes resulted in an inhibition of (3H)choline uptake accompanied by an inhibition of Na+, K+-adenosine triphosphatase activity. In contrast to the increase of (3H)HCh-3 binding, the specific binding of both (3H)desipramine and (3H)mazindol was decreased by PLA2 treatment. After PLA2 treatment, (3H)HCh-3 binding was increased about 2.5-fold over basal levels in different regions of the brain. Electrolytic lesions of the medial septal nucleus and kainic acid-induced lesions of the striatum resulted in a marked reduction of (3H)HCh-3 binding in the hippocampus and the striatum, respectively. Residual (3H)HCh-3 binding in the denervated hippocampus and lesioned striatum was increased by PLA2 treatment but remained lower than that in PLA2-treated controls. Finally, atropine-induced up-regulation of (3H)HCh-3 binding in vivo was not additive with PLA2-induced stimulation. These results support the hypothesis that PLA2 might be involved in the regulation of the sodium-dependent high-affinity choline uptake.
OSTI ID:
5564302
Journal Information:
Journal of Pharmacology and Experimental Therapeutics; (USA), Journal Name: Journal of Pharmacology and Experimental Therapeutics; (USA) Vol. 249:3; ISSN 0022-3565; ISSN JPETA
Country of Publication:
United States
Language:
English